Gastric adaptation to injury during repeated doses of acetyl salicylic acid (ASA) is a well documented finding but it is not known whether this adaptation affects the tolerance of the mucosa to other strong irritants. Gastric adaptation was induced by repeated daily doses of acidified ASA (100 mglkg in 1-5 ml of 0.2 N HCl) given intragastrically (series A rats). Control rats with an intact stomach were given daily intragastric vehicle only (1.5 ml of 0.2 N HCI) (series B). After full adaptation to ASA (5 days), rats were challenged again with acidified ASA or, for comparison, with strong irritants such as 100% ethanol, 200 mM acidified taurocholate, or 25% NaCl for 1 hour or with water immersion and restraint for 3.5 hours. The first dose of ASA produced numerous gastric lesions and deep histological necrosis accompanied by a fall in the gastric blood flow, negligible expression of epidermal growth factor (EGF) and transforming growth factor a (TGFa) or their receptors, and no evidence of mucosal proliferation. As adaptation to ASA developed, however, the areas of gastric lesions were reduced by more than 80% and there was a noticeable decrease in deep necrosis, a partial restoration of gastric blood flow, an approximately fourfold increase in EGF expression (but not in TGFIa) and its receptors, and an appreciable increase in mucosal celi proliferation compared with vehicle treated rats. Increases in the mucosal expression of EGF receptors and the luminal content of EGF were also found in ASA adapted animals. In ASA adapted rats subsequently challenged with 100% ethanol, 200 mM TC, 25% NaCI, or stress, the area of the gastric lesions and deep histological necrosis were appreciably reduced compared with values in vehicle treated rats. This increased mucosal tolerance to strong irritants was also accompanied by the return of the gastric blood flow towards control levels and further significant increases in the mucosal expression of EGF receptors and mucosal cell proliferation. Gastric adaptation to ASA enhances the mucosal resistance to injury by strong irritants probably as a result of the restoration of the gastric blood flow and increased celi proliferation that may result from increased mucosal expression of EGF and its receptors. (Gut 1995; 37: 749-757) 
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Long term gastric adaptation develops in response to repeated exposure of the gastric mucosa to various irritants. 1 2This adaptation was originally shown in gastric mucosa exposed to non-steroidal anti-inflammatory drugs (NSAID) including acetyl salicylic acid (ASA)3-6 and indomethacin,7 necrotising substances,8-1 or stress12 but neither the mechanism of this adaptation nor its influence on gastric mucosal defence against the damage by necrotising substances has been explored.
ASA and related agents given for the first time in a single dose may cause widespread damage to the surface epithelium and deep haemorrhagic lesions. The pathogenesis of NSAID gastropathy is poorly understood but it has been attributed to the topical irritation of the mucosa associated with the inhibition of mucosal prostaglandin generation and vascular injury as a result of neutrophil activation and thrombi formation. [13] [14] [15] [16] We reported recently that with repeated daily doses of ASA,17 18 Acute gastric lesions were induced by an intragastric application of acidified ASA in male Wistar rats weighing 180-220 g. The animals were fasted overnight in individual cages but had free access to water. There were two series of rats, A and B, each comprising 80 rats. Series A animals received intragastric ASA (100 mg/kg dissolved in 1-5 ml of 0.2 N HC1 daily) and series B animals were given intragastric vehicle only (1.5 ml of 0.2 N HCI daily).
Gastric adaptation in series A rats was achieved by repeated intragastric administration of acidified ASA, daily for five consecutive days as described in detail previously. 18 Briefly, one group of rats received acidified ASA at a dose of 100 mg/kg at 10.00 am and was killed one hour later (day 0). Another group also received acidified ASA (100 mg/kg) at 10.00 am but one hour later was refed until 5.00 pm, fasted overnight, given acidified ASA the next day at 10.00 am, and killed one hour later (day 1). Other groups underwent the same schedule of refeeding and refasting for 2, 3, or 4 consecutive days (day 2, 3, and 4, respectively) after the first exposure to ASA and were then killed. Next day, after five repeated daily doses of acidified ASA, when the adaptation to ASA was fully developed, and after an 18 hour fast rats of series A were divided into five groups (each consisting 8-10 animals) and challenged intragastrically with 1.5 ml of one of the following: acidified ASA, 100% ethanol, 200 mM taurocholate, or 25% NaCI and killed after one hour or underwent water immersion and restraint stress and were killed after 3-5 hours as described before.'2 For comparison, unadapted, vehicle treated rats with an intact stomach (series B) treated intragastrically for four days with 1.5 ml of saline were divided into five groups of 8-10 rats each and were challenged with the same ulcerogens as the rats in series A.
MEASUREMENT OF THE GASTRIC BLOOD FLOW
One hour after each of the topical ulcerogens had been applied intragastrically or after 3.5 hours of stress, the rats were lightly anaesthetised with ether and the gastric blood flow was measured in the oxyntic gland area of the stomach by means of local H2 gas clearance technique using an electrolytic regional blood flow meter (Biomedical Science, Model RBF-2, Japan). The double needle electrodes were inserted through the serosa into the mucosa, one electrode was used for local generation of H2 gas and the other for the measurement of tissues H2. With this technique, the H2 generated by the electrode is carried away by the flowing blood and the polarographic current detector gives the decreasing tissue H2 as the clearance curve, which is then used to calculate absolute values of the blood flow (mVl100 g-min) in the tissue as described previously. ' In series A and B rats, mucosal biopsy samples of the oxyntic gland area (about 100 mg) were taken immediately after the animals had been killed to determine the mucosal generation of prostaglandin E2 by specific radioimmunoassay (RIA) as described previously.'9 The mucosal sample was placed in preweighted Eppendorf vials and 1 ml of Tris buffer (50 mM, pH 3.5) was added to each vial. The samples were finely minced (for about 15 seconds) with scissors, washed, and centrifuged for 10 seconds, and the pellet was resuspended in 1 ml of Tris. Each sample was then incubated on a vortex mixer for 1 minute and centrifuged for 15 seconds. The pellet was weighed and the supernatant was transferred to a second Eppendorf vial containing indomethacin (10 mM) and kept at -20°C until RIA. Prostaglandin E2 was measured in duplicate using RIA kits (New England Nuclear, Munich, Germany). The For the determination of the luminal concentration of EGF, the cardia and the pylorus were ligated (after the blood flow had been measured) and 1 ml of cold saline was instilled into the stomach to wash out the gastric contents. Each sample was centrifuged: the supernatant was collected, neutralised with 0-1 N Na(OH) to pH 7.0, and frozen at -20°C until EGF RIA. In series A and B, the mucosal samples (about 100 mg) were excised from the oxyntic gland area of the stomach for determination of the mucosal EGF content by RIA.18 The tissue samples were immediately weighed, homogenised in ice cold 0.32 M Tris-HCl buffer, and centrifuged: the supernatant was collected and frozen at -20C until EGF radioimmunoassay. The EGF antiserum (gift of Dr H Gregory, ICI, Alderly Park, UK), raised in rabbits against human EGF was used at a final dilution of 1:210 000 and this antiserum recognised equally rat and human EGF.
Iodinated ([3-125I] iodotyrosyl) peptide and rat
EGF were calibration standards (Amersham, UK). The detection limit of the assay was 0.01 nmoll. The intrassay and interassay precision were about 12% and 10%, respectively.
MUCOSAL HISTOLOGY AND EXPRESSION OF EGF AND TGFaL AND THEIR RECEPTOR
In some experiments, standardised strips incorporating the total width of stomachs were fixed in 10% buffered formalin and paraffin sections were stained with haematoxylin and eosin (H & E) for histological evaluation. A Nikon microscope equipped with microplan II digital image system was used for the quantitative histological examination (morphometry) of the sections. Coded specimens of mucosa stained with H & E were evaluated quantitatively under 500X magnification in blinded conditions. The disrupted surface of the mucosal strips denuded of epithelium, the deep necrotic lesions penetrating the mucosa, and the strip length with regeneration of the surface epithelium cells were measured and expressed as a percentage of the total. Coded specimens of mucosa stained with H & E were evaluated quantitatively under 500X magnification under blinded conditions. In addition, serial sections of paraffin embedded blocks were dewaxed, rehydrated, slides pretreated with citrate buffer (pH 6) in a microwave oven (3X5 min), and immunostained with specific monoclonal antibodies against EGF (1:40, GFO.1, Oncogene), TGFot (1:20, GF1O Acidified ASA, given orally for the first time (once), produced an increase in gastric erosions at a dose of 100 mg/kg that reached a mean area of about 60 mm2 (Table I ). The area of gastric lesions was already significantly decreased the next day after the rechallenge with acidified ASA. After the next 4 days of ASA rechallenge, a marked decrease in the area of macroscopic gastric lesions was observed, indicating that full adaptation to acidified ASA had been achieved (Fig 1) .
Gastric blood flow, which in the intact, vehicle treated stomach averaged 49 (7) ml/min per 100 g, was significantly decreased by about 60% after the first exposure to ASA (Table I) length, respectively, and the lack of regenera-(6), 82 (8), 40 tive changes was noticed in these animals. In )ectively (Fig 2) . contrast, rats adapted to ASA and challenged rere reduction in with 100% ethanol, 200 mM TC, 25% NaCl, d with the value acidified ASA, or stress, showed a significant eated only with reduction in the deep necrosis associated with laptation subse-the increase in mucosal regeneration compared with acidified with changes observed in unadapted rats lanol, 200 mM exposed to each of the irritants (Table II) 
MUCOSAL EXPRESSION OF EGF AND TGFaO AND THEIR RECEPTORS AND LUMINAL AND MUCOSAL CONTENTS OF EGF
As shown in Figure 3, (0 2) but this was not significantly changed upon the adaptation of mucosa to ASA (see Fig 3) .
In the vehicle treated gastric mucosa, EGF receptor (EGFr) was expressed in some neck cells, mainly at their luminal plasma membranes, and in some single parietal cells (Fig 7) . After first exposure to acidified ASA, the expression of EGFr was diminished or absent in the area of deep necrotic lesions, while in non-necrotic mucosa the expression of EGFr was not significantly affected compared with that in the intact gastric mucosa (Table III) . After repeat ASA insults, a significant increase in EGFr expression was observed in non-necrotic mucosa (Fig 8) . In some surface epithelium cells, especially in regenerating mucosa with elongated foveolae and neck region, the expression was seen in both foveolar and neck cells. In these areas ofregenerative mucosa, increases in the expression of EGFr in the neck region and the deeper areas of oxyntic mucosa were also observed. The expression of EGFr was diminished or absent in the areas of deep necrotic lesions in unadapted rats challenged with 100% ethanol, 200 mM TC, or 25% NaCl. In contrast, the gastric mucosa of rats adapted to ASA and then challenged with 100% ethanol, 200 m1M TC, or 25% NaCl showed enhancement in expression of EGFr similar to that in rats adapted to ASA and challenged with ASA and other irritants, especially in areas with strong regeneration of the mucosal surface area. Table III shows the immunoreactivity of EGF in the gastric mucosa and in gastric juice in rats adapted to repeated ASA insults with or without the challenge with various strong irritants. The single exposure to ASA failed to affect significantly the mucosal and luminal content of EGF compared with that measured in animals with an intact stomach. The luminal and mucosal EGF contents gradually increased with consecutive ASA insults compared to values in rats exposed to a single dose of ASA. The mucosal content of EGF --~~~~~~~-r. remained unchanged in unadapted rats challenged with 100% ethanol, 200 mM TC, or 25% NaCI but it reached significantly higher values in rats exposed to repetitive ASA insults. In rats adapted to ASA and challenged with acidified ASA, 100% ethanol, 200 mM TC, 25% NaCl, or stress, there was a significant increase in the luminal and mucosal contents of EGF compared with values in respective unadapted rats exposed to each of the irritants.
Discussion
The present study confirms our previous observations'7 18 that the rat stomach has the ability to resist further damage despite continuous exposure to acidified ASA. This adaptation is accompanied by restoration of the gastric blood flow, increased expression of EGF and its receptors, and an increase in the luminal EGF contents. Furthermore, the gastric mucosa adapted to ASA is remarkably resistant to the injury caused by necrotising substances such as absolute ethanol, 200 mM TC, 25% NaCl, or by stress. This reduction in the formation of acute gastric lesions in the ASA adapted stomach in response to challenge with noxious agents is accompanied by gastric hyperaemia, a noticeable increase in the mucosal expression of EGF and its receptor, and an impressive increase in mucosal cell regeneration. Adaptation describes the phenomenon in which visible gastric mucosal injury lessens or resolves completely despite continued insults of injurious agents such as ASA. We have reported that the gastric mucosa adapts to repeated ASA17 18 or stress12 insults and that this is accompanied by gastric hyperaemia, probably mediated by sensory nerves but not by endogenous prostaglandin, at least in the case of adaptation to ASA. 17 18 In this study, the first exposure to ASA reduced gastric blood flow considerably but upon adaptation to injury by repeated exposure to ASA, the gastric blood flow tended to return to a value similar to that recorded in the intact mucosa. Mucosal generation of prostaglandin E2 was inhibited with the first dose of ASA and remained suppressed throughout adaptation to ASA and subsequent insults by various irritants, confirming that endogenous prostaglandins are not required for the development of this adaptation, the accompanying gastric hyperaemia, or increased mucosal defence against various topical irritants.
The role of prostaglandins in the short term adaptation of the gastric mucosa to damage by various ulcerogens was originally examined by Robert et al.22 23 They first showed that oral administration of mild irritants such as 10-20% ethanol Similarly to ASA in our study, the initial exposure to 100% ethanol, 25% NaCl, or 200 mM TC caused widespread damage to the surface epithelium and deep necrotic lesions accompanied by a fall in the gastric blood flow and the absence of the expression of receptors for EGF. However, rats adapted to ASA and then challenged with 100% ethanol, 200 mM TC, or 25% NaCl showed a marked reductioh in ulcerogenesis, and this was accompanied by a significant rise in gastric blood flow and by expression of EGF and its receptors to an extent similar to that observed in rats adapted to ASA. This suggests that the enhanced production of EGF and augmentation of specific receptor sites for this peptide may contribute to the adaptation and to the enhanced resistance of the gastric mucosa to injury caused by necrotising agents. The regeneration of gastric mucosa during gastric adaptation to ASA is probably mediated predominantly by EGF because in addition to the rise in the mucosal expression of EGF and its receptor, the luminal contents of immunoreactive EGF were significantly increased during adaptation and remained raised in ASA adapted rats challenged with strong irritants. Salivary EGF could play a part in the process of mucosal repair and adaptation because, as previously observed, the formation of submandibulary EGF was significantly increased after the exposure of gastric mucosa to acid dependent or acid independent ulcerogens.36 Indeed, in our present study the luminal content of EGF was markedly increased after adaptation to ASA and after challenge with strong irritants, indicating that EGF of salivary origin may interact with specific receptors over expressed in the mucosa and this may be essential for the regeneration observed during adaptation to these ulcerogens. This notion is supported by our recent observation12 that removal of salivary glands abolished gastric adaptation to stress and reduced that of ASA12 18 and this was accompanied by a significant decrease in the luminal contents of EGF. Since damaged gastric mucosa is capable of secreting EGF from the novel cell lineages,37 it is likely, that gastric luminal EGF in the ASA adapted stomach originates from local gastric production rather than from the excessive release by salivary glands. That the changes in EGF and EGFr could be, at least partly, epiphenomena related to excessive mucosal regeneration and may not be directly responsible for the resistance of the epithelium to further damage has not been excluded.
Our previous study38-40 using specific receptor binding assay showed that normal gastric mucosa expresses receptors for TGFa and EGF, and that both peptides were equally effective in protection against the damage induced by strong irritants. That an augmented local expression ofTGFox which shares a common high affinity receptor with EGF40 41 and is greatly increased after acute mucosal damage with hyperosmolar solution,41 could also participate in the gastric adaptation to ASA and enhanced resistance of the ASA adapted mucosa against the damage by strong irritant has not been excluded. Our present results show, however, that although normal mucosa exhibits relatively higher expression of TGFa than of EGF, the ASA adapted mucosa exhibits an enhanced expression only of EGF but shows no further increase in TGFox expression. It is reasonable, therefore, to assume that EGF rather than TGFox plays a crucial role in the gastric adaptation to ASA and in the subsequent increase in the mucosal tolerance to necrotising substances.
